Allogeneic Hematopoietic Stem Cell Transplantation With JSP191-Based Conditioning in Participants With GATA2 Deficiency
Conditions: GATA2; Immunodeficiency Interventions: Drug: Mycophenolate Mofetil; Drug: Tacrolimus; Drug: Post-Transplant Cyclophosphamide; Radiation: Total Body Irradiation; Procedure: Hematopoietic Cell Transplant; Drug: JSP191; Drug: Cyclophosphamide; Drug: Fludarabine Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Prograf | Research | Stem Cell Therapy | Stem Cells | Tacrolimus | Transplants